<DOC>
	<DOC>NCT00433875</DOC>
	<brief_summary>Twelve week treatment of AMG 714 in RA patients who failed at least one DMARD, followed by a 3 month observational period.</brief_summary>
	<brief_title>Phase 2 AMG 714 in Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Diagnosis of RA No prior biologic treatment for RA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>